dr vidya veldore - interpretation of met amplification on exon 14 skip mutation in nsclc
Published 2 years ago • 90 plays • Length 18:22Download video MP4
Download video MP3
Similar videos
-
16:56
dr siddharth turkar -selection of 1st line therapy for met amplification and met exon 14 mutation in
-
24:00
molecular workshop dr vidya veldore why liquid biopsy is important in clinical routine
-
4:07
dr. besse discusses mariposa analysis on mechanisms of acquired resistance
-
3:07
lung cancer: diagnosis and treatment │ dr. devavrat arya│ max hospital, saket
-
26:02
machine learning aided discovery of potential biomarkers for cancer diagnosis and prognosis
-
11:27
distinguish malignant vs. benign lung nodules
-
1:51:34
a podcast on role of liquid biopsy in cancer treatment - diagnosis to prognosis
-
17:38
lung nodules (basics for patients)
-
1:15
dll3, a new biomarker for neuroendocrine tumors of the lung
-
2:44
the new standard in lung cancer diagnostics
-
21:07
recognizing wpoi-5 teaching module by dr. margaret brandwein
-
2:25
prophylactic cranial irradiation for extensive stage small cell lung cancer
-
30:14
early diagnosis of lung cancer
-
4:35
tabrecta - lung cancer treatment
-
2:42
improving lung cancer diagnosis
-
23:47
diversity in cancer care | lung cancer | challenges in treatment
-
1:18
dr. hoffman-censits on biomarker development in urothelial carcinoma
-
0:31
lung cancer screening: what to know
-
2:08
mariposa: mechanisms of resistance to 1l amivantamab lazertinib in pts with egfr-m nsclc
-
18:17
part 2: scientifically published views about cancer and the challenges faced by researchers
-
4:53
how does low-dose ct show whether i have lung cancer?
-
2:39
screening for lung cancer